Heparin

Geriatric
  • TRADE NAMES: Calcilean; Calciparin; Caprin; Hep-Flush (Wyeth); Hep-Lock; Hepalean; Heparin-Leo; Heparine; Liquemin; Uniparin; Viaflex (Baxter)
  • INDICATIONS: Venous thrombosis, pulmonary embolism, intravascular coagulation, peripheral arterial embolism
  • CLASS: Anticoagulant, Heparinoid
  • HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Acenocoumarol, Aliskiren, Antihistamines, Aspirin, Balsalazide, Bivalirudin, Butabarbital, Ceftobiprole, Dabigatran, Danaparoid, Defibrotide, Desvenlafaxine, Iloprost, Nandrolone, Nicotine, Nitroglycerin, Palifermin, Piperacillin/Tazobactam, Salicylates, Tirofiban, Warfarin

PREGNANCY CATEGORY: C

A higher incidence of bleeding has been reported in patients over 60 years of age, especially women.

Contra-indicated in patients with severe thrombocyopenia.

Our database has 55 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
NEUROMUSCULAR/SKELETAL
OTHER


Page last updated 01/30/2019

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric